Brigham Young University

There are just two chimeric antigen receptor T-cell (CAR-T) therapies approved in the US, but dozens of companies already are clamoring to bring the next generation of CAR-T products to the market tha

In the market for minimally invasive surgery (MIS) products, one of the hottest and fastest growing segments is robotically assisted surgical devices (RASD). In the last 15 years, Intuitive Surgical

IN VITRO DIAGNOSTICS VitaPath Genetics Inc. VitaPath brings in $7.3mm via Series C round VitaPath Genetics Inc. (developing DNA tests to identify women at high risk for birth defects) has rais

[Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog .] In a deal structure that perhaps could